NCT02696967View on ClinicalTrials.gov

A Study of CLR325 in Chronic Stable Heart Failure Patients.

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

May 17, 2016

Primary Completion Date

January 14, 2019

Study Completion Date

January 14, 2019

Conditions
Chronic Stable Heart Failure
Interventions
DRUG

CLR325

CLR325 Concentrate for solution for infusion

OTHER

Placebo

Normal saline

Trial Locations (11)

9300

Novartis Investigative Site, Aalst

17475

Novartis Investigative Site, Greifswald

19104

Novartis Investigative Site, Philadelphia

44195

Novartis Investigative Site, Cleveland

60611

Novartis Investigative Site, Chicago

63110

Novartis Investigative Site, St Louis

77030

Novartis Investigative Site, Houston

93053

Novartis Investigative Site, Regensburg

98405

Novartis Investigative Site, Tacoma

169609

Novartis Investigative Site, Singapore

1081 HV

Novartis Investigative Site, Amsterdam

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY